<code id='BF1E880AB3'></code><style id='BF1E880AB3'></style>
    • <acronym id='BF1E880AB3'></acronym>
      <center id='BF1E880AB3'><center id='BF1E880AB3'><tfoot id='BF1E880AB3'></tfoot></center><abbr id='BF1E880AB3'><dir id='BF1E880AB3'><tfoot id='BF1E880AB3'></tfoot><noframes id='BF1E880AB3'>

    • <optgroup id='BF1E880AB3'><strike id='BF1E880AB3'><sup id='BF1E880AB3'></sup></strike><code id='BF1E880AB3'></code></optgroup>
        1. <b id='BF1E880AB3'><label id='BF1E880AB3'><select id='BF1E880AB3'><dt id='BF1E880AB3'><span id='BF1E880AB3'></span></dt></select></label></b><u id='BF1E880AB3'></u>
          <i id='BF1E880AB3'><strike id='BF1E880AB3'><tt id='BF1E880AB3'><pre id='BF1E880AB3'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:78
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal
          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

          CourtesySanofiLONDON—Inabidtoexpanditspipelineofinflammation-targetingdrugs,SanofisaidTuesdayitwasac

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Morgan Health, with ambitious aims, wants you to know it’s still here

          AdobeSANFRANCISCO—Almostthreeyearsago,thecountry’sbiggestbankunveiledaloftyplantofixthehealthcareind